Vyas, H.S.; Jadeja, R.N.; Vohra, A.; Upadhyay, K.K.; Thounaojam, M.C.; Bartoli, M.; Devkar, R.V.
CORM-A1 Alleviates Pro-Atherogenic Manifestations via miR-34a-5p Downregulation and an Improved Mitochondrial Function. Antioxidants 2023, 12, 997.
https://doi.org/10.3390/antiox12050997
AMA Style
Vyas HS, Jadeja RN, Vohra A, Upadhyay KK, Thounaojam MC, Bartoli M, Devkar RV.
CORM-A1 Alleviates Pro-Atherogenic Manifestations via miR-34a-5p Downregulation and an Improved Mitochondrial Function. Antioxidants. 2023; 12(5):997.
https://doi.org/10.3390/antiox12050997
Chicago/Turabian Style
Vyas, Hitarthi S., Ravirajsinh N. Jadeja, Aliasgar Vohra, Kapil K. Upadhyay, Menaka C. Thounaojam, Manuela Bartoli, and Ranjitsinh V. Devkar.
2023. "CORM-A1 Alleviates Pro-Atherogenic Manifestations via miR-34a-5p Downregulation and an Improved Mitochondrial Function" Antioxidants 12, no. 5: 997.
https://doi.org/10.3390/antiox12050997
APA Style
Vyas, H. S., Jadeja, R. N., Vohra, A., Upadhyay, K. K., Thounaojam, M. C., Bartoli, M., & Devkar, R. V.
(2023). CORM-A1 Alleviates Pro-Atherogenic Manifestations via miR-34a-5p Downregulation and an Improved Mitochondrial Function. Antioxidants, 12(5), 997.
https://doi.org/10.3390/antiox12050997